img

Global Medical Antifungal Agent Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Medical Antifungal Agent Market Insights, Forecast to 2034

Antifungals are medicines that kill or stop the growth of fungi that cause infections.
Global Medical Antifungal Agent market is expected to reach to US$ 13620 million in 2024, with a positive growth of %, compared with US$ 13030 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Medical Antifungal Agent industry is evaluated to reach US$ 16170 million in 2029. The CAGR will be 2.9% during 2024 to 2029.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2024, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers
This report presents an overview of global Medical Antifungal Agent market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Medical Antifungal Agent market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novartis
Pfizer
Bayer
Sanofi
Merck & Co
GlaxoSmithKline
MSD Manuals
Abbott
Glenmark
Enzon Pharmaceuticals
Astellas Pharma
Scynexis
Cidara Therapeutics
Lucigen Corporation
Biosergen
F2G
Sichuan Meidakang Pharmaceutical
Chengdu Taihe Health Technology
Segment by Type
Azoles
Echinocandins
Polyenes
Allylamines
Others

Segment by Application


Dermatophytosis
Aspergillosis
Candidiasis
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Medical Antifungal Agent plant distribution, commercial date of Medical Antifungal Agent, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Medical Antifungal Agent introduction, etc. Medical Antifungal Agent Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Medical Antifungal Agent
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Medical Antifungal Agent Product Introduction
1.2 Market by Type
1.2.1 Global Medical Antifungal Agent Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Azoles
1.2.3 Echinocandins
1.2.4 Polyenes
1.2.5 Allylamines
1.2.6 Others
1.3 Market by Application
1.3.1 Global Medical Antifungal Agent Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Dermatophytosis
1.3.3 Aspergillosis
1.3.4 Candidiasis
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Medical Antifungal Agent Sales Estimates and Forecasts 2018-2029
2.2 Global Medical Antifungal Agent Revenue by Region
2.2.1 Global Medical Antifungal Agent Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Medical Antifungal Agent Revenue by Region (2018-2024)
2.2.3 Global Medical Antifungal Agent Revenue by Region (2024-2029)
2.2.4 Global Medical Antifungal Agent Revenue Market Share by Region (2018-2029)
2.3 Global Medical Antifungal Agent Sales Estimates and Forecasts 2018-2029
2.4 Global Medical Antifungal Agent Sales by Region
2.4.1 Global Medical Antifungal Agent Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Medical Antifungal Agent Sales by Region (2018-2024)
2.4.3 Global Medical Antifungal Agent Sales by Region (2024-2029)
2.4.4 Global Medical Antifungal Agent Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Medical Antifungal Agent Sales by Manufacturers
3.1.1 Global Medical Antifungal Agent Sales by Manufacturers (2018-2024)
3.1.2 Global Medical Antifungal Agent Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Medical Antifungal Agent in 2022
3.2 Global Medical Antifungal Agent Revenue by Manufacturers
3.2.1 Global Medical Antifungal Agent Revenue by Manufacturers (2018-2024)
3.2.2 Global Medical Antifungal Agent Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Medical Antifungal Agent Revenue in 2022
3.3 Global Key Players of Medical Antifungal Agent, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Medical Antifungal Agent Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Medical Antifungal Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Medical Antifungal Agent, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Medical Antifungal Agent, Product Offered and Application
3.8 Global Key Manufacturers of Medical Antifungal Agent, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Medical Antifungal Agent Sales by Type
4.1.1 Global Medical Antifungal Agent Historical Sales by Type (2018-2024)
4.1.2 Global Medical Antifungal Agent Forecasted Sales by Type (2024-2029)
4.1.3 Global Medical Antifungal Agent Sales Market Share by Type (2018-2029)
4.2 Global Medical Antifungal Agent Revenue by Type
4.2.1 Global Medical Antifungal Agent Historical Revenue by Type (2018-2024)
4.2.2 Global Medical Antifungal Agent Forecasted Revenue by Type (2024-2029)
4.2.3 Global Medical Antifungal Agent Revenue Market Share by Type (2018-2029)
4.3 Global Medical Antifungal Agent Price by Type
4.3.1 Global Medical Antifungal Agent Price by Type (2018-2024)
4.3.2 Global Medical Antifungal Agent Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Medical Antifungal Agent Sales by Application
5.1.1 Global Medical Antifungal Agent Historical Sales by Application (2018-2024)
5.1.2 Global Medical Antifungal Agent Forecasted Sales by Application (2024-2029)
5.1.3 Global Medical Antifungal Agent Sales Market Share by Application (2018-2029)
5.2 Global Medical Antifungal Agent Revenue by Application
5.2.1 Global Medical Antifungal Agent Historical Revenue by Application (2018-2024)
5.2.2 Global Medical Antifungal Agent Forecasted Revenue by Application (2024-2029)
5.2.3 Global Medical Antifungal Agent Revenue Market Share by Application (2018-2029)
5.3 Global Medical Antifungal Agent Price by Application
5.3.1 Global Medical Antifungal Agent Price by Application (2018-2024)
5.3.2 Global Medical Antifungal Agent Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Medical Antifungal Agent Market Size by Type
6.1.1 US & Canada Medical Antifungal Agent Sales by Type (2018-2029)
6.1.2 US & Canada Medical Antifungal Agent Revenue by Type (2018-2029)
6.2 US & Canada Medical Antifungal Agent Market Size by Application
6.2.1 US & Canada Medical Antifungal Agent Sales by Application (2018-2029)
6.2.2 US & Canada Medical Antifungal Agent Revenue by Application (2018-2029)
6.3 US & Canada Medical Antifungal Agent Market Size by Country
6.3.1 US & Canada Medical Antifungal Agent Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Medical Antifungal Agent Sales by Country (2018-2029)
6.3.3 US & Canada Medical Antifungal Agent Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Medical Antifungal Agent Market Size by Type
7.1.1 Europe Medical Antifungal Agent Sales by Type (2018-2029)
7.1.2 Europe Medical Antifungal Agent Revenue by Type (2018-2029)
7.2 Europe Medical Antifungal Agent Market Size by Application
7.2.1 Europe Medical Antifungal Agent Sales by Application (2018-2029)
7.2.2 Europe Medical Antifungal Agent Revenue by Application (2018-2029)
7.3 Europe Medical Antifungal Agent Market Size by Country
7.3.1 Europe Medical Antifungal Agent Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Medical Antifungal Agent Sales by Country (2018-2029)
7.3.3 Europe Medical Antifungal Agent Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Medical Antifungal Agent Market Size
8.1.1 China Medical Antifungal Agent Sales (2018-2029)
8.1.2 China Medical Antifungal Agent Revenue (2018-2029)
8.2 China Medical Antifungal Agent Market Size by Application
8.2.1 China Medical Antifungal Agent Sales by Application (2018-2029)
8.2.2 China Medical Antifungal Agent Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Medical Antifungal Agent Market Size by Type
9.1.1 Asia Medical Antifungal Agent Sales by Type (2018-2029)
9.1.2 Asia Medical Antifungal Agent Revenue by Type (2018-2029)
9.2 Asia Medical Antifungal Agent Market Size by Application
9.2.1 Asia Medical Antifungal Agent Sales by Application (2018-2029)
9.2.2 Asia Medical Antifungal Agent Revenue by Application (2018-2029)
9.3 Asia Medical Antifungal Agent Sales by Region
9.3.1 Asia Medical Antifungal Agent Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Medical Antifungal Agent Revenue by Region (2018-2029)
9.3.3 Asia Medical Antifungal Agent Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Medical Antifungal Agent Market Size by Type
10.1.1 Middle East, Africa and Latin America Medical Antifungal Agent Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Medical Antifungal Agent Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Medical Antifungal Agent Market Size by Application
10.2.1 Middle East, Africa and Latin America Medical Antifungal Agent Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Medical Antifungal Agent Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Medical Antifungal Agent Sales by Country
10.3.1 Middle East, Africa and Latin America Medical Antifungal Agent Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Medical Antifungal Agent Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Medical Antifungal Agent Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Novartis Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Pfizer Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Overview
11.3.3 Bayer Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Bayer Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bayer Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Sanofi Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Recent Developments
11.5 Merck & Co
11.5.1 Merck & Co Company Information
11.5.2 Merck & Co Overview
11.5.3 Merck & Co Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Merck & Co Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck & Co Recent Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Information
11.6.2 GlaxoSmithKline Overview
11.6.3 GlaxoSmithKline Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 GlaxoSmithKline Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GlaxoSmithKline Recent Developments
11.7 MSD Manuals
11.7.1 MSD Manuals Company Information
11.7.2 MSD Manuals Overview
11.7.3 MSD Manuals Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 MSD Manuals Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 MSD Manuals Recent Developments
11.8 Abbott
11.8.1 Abbott Company Information
11.8.2 Abbott Overview
11.8.3 Abbott Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Abbott Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Abbott Recent Developments
11.9 Glenmark
11.9.1 Glenmark Company Information
11.9.2 Glenmark Overview
11.9.3 Glenmark Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Glenmark Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Glenmark Recent Developments
11.10 Enzon Pharmaceuticals
11.10.1 Enzon Pharmaceuticals Company Information
11.10.2 Enzon Pharmaceuticals Overview
11.10.3 Enzon Pharmaceuticals Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Enzon Pharmaceuticals Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Enzon Pharmaceuticals Recent Developments
11.11 Astellas Pharma
11.11.1 Astellas Pharma Company Information
11.11.2 Astellas Pharma Overview
11.11.3 Astellas Pharma Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Astellas Pharma Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Astellas Pharma Recent Developments
11.12 Scynexis
11.12.1 Scynexis Company Information
11.12.2 Scynexis Overview
11.12.3 Scynexis Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Scynexis Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Scynexis Recent Developments
11.13 Cidara Therapeutics
11.13.1 Cidara Therapeutics Company Information
11.13.2 Cidara Therapeutics Overview
11.13.3 Cidara Therapeutics Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Cidara Therapeutics Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Cidara Therapeutics Recent Developments
11.14 Lucigen Corporation
11.14.1 Lucigen Corporation Company Information
11.14.2 Lucigen Corporation Overview
11.14.3 Lucigen Corporation Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Lucigen Corporation Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Lucigen Corporation Recent Developments
11.15 Biosergen
11.15.1 Biosergen Company Information
11.15.2 Biosergen Overview
11.15.3 Biosergen Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Biosergen Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Biosergen Recent Developments
11.16 F2G
11.16.1 F2G Company Information
11.16.2 F2G Overview
11.16.3 F2G Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 F2G Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 F2G Recent Developments
11.17 Sichuan Meidakang Pharmaceutical
11.17.1 Sichuan Meidakang Pharmaceutical Company Information
11.17.2 Sichuan Meidakang Pharmaceutical Overview
11.17.3 Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Sichuan Meidakang Pharmaceutical Recent Developments
11.18 Chengdu Taihe Health Technology
11.18.1 Chengdu Taihe Health Technology Company Information
11.18.2 Chengdu Taihe Health Technology Overview
11.18.3 Chengdu Taihe Health Technology Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 Chengdu Taihe Health Technology Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Chengdu Taihe Health Technology Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Medical Antifungal Agent Industry Chain Analysis
12.2 Medical Antifungal Agent Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Medical Antifungal Agent Production Mode & Process
12.4 Medical Antifungal Agent Sales and Marketing
12.4.1 Medical Antifungal Agent Sales Channels
12.4.2 Medical Antifungal Agent Distributors
12.5 Medical Antifungal Agent Customers
13 Market Dynamics
13.1 Medical Antifungal Agent Industry Trends
13.2 Medical Antifungal Agent Market Drivers
13.3 Medical Antifungal Agent Market Challenges
13.4 Medical Antifungal Agent Market Restraints
14 Key Findings in The Global Medical Antifungal Agent Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Medical Antifungal Agent Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Azoles
Table 3. Major Manufacturers of Echinocandins
Table 4. Major Manufacturers of Polyenes
Table 5. Major Manufacturers of Allylamines
Table 6. Major Manufacturers of Others
Table 7. Global Medical Antifungal Agent Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Medical Antifungal Agent Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Medical Antifungal Agent Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Medical Antifungal Agent Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global Medical Antifungal Agent Revenue Market Share by Region (2018-2024)
Table 12. Global Medical Antifungal Agent Revenue Market Share by Region (2024-2029)
Table 13. Global Medical Antifungal Agent Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Medical Antifungal Agent Sales by Region (2018-2024) & (K Units)
Table 15. Global Medical Antifungal Agent Sales by Region (2024-2029) & (K Units)
Table 16. Global Medical Antifungal Agent Sales Market Share by Region (2018-2024)
Table 17. Global Medical Antifungal Agent Sales Market Share by Region (2024-2029)
Table 18. Global Medical Antifungal Agent Sales by Manufacturers (2018-2024) & (K Units)
Table 19. Global Medical Antifungal Agent Sales Share by Manufacturers (2018-2024)
Table 20. Global Medical Antifungal Agent Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Medical Antifungal Agent Revenue Share by Manufacturers (2018-2024)
Table 22. Global Key Players of Medical Antifungal Agent, Industry Ranking, 2021 VS 2022 VS 2024
Table 23. Medical Antifungal Agent Price by Manufacturers 2018-2024 (US$/Unit)
Table 24. Global Medical Antifungal Agent Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Medical Antifungal Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Antifungal Agent as of 2022)
Table 26. Global Key Manufacturers of Medical Antifungal Agent, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Medical Antifungal Agent, Product Offered and Application
Table 28. Global Key Manufacturers of Medical Antifungal Agent, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Medical Antifungal Agent Sales by Type (2018-2024) & (K Units)
Table 31. Global Medical Antifungal Agent Sales by Type (2024-2029) & (K Units)
Table 32. Global Medical Antifungal Agent Sales Share by Type (2018-2024)
Table 33. Global Medical Antifungal Agent Sales Share by Type (2024-2029)
Table 34. Global Medical Antifungal Agent Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Medical Antifungal Agent Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global Medical Antifungal Agent Revenue Share by Type (2018-2024)
Table 37. Global Medical Antifungal Agent Revenue Share by Type (2024-2029)
Table 38. Medical Antifungal Agent Price by Type (2018-2024) & (US$/Unit)
Table 39. Global Medical Antifungal Agent Price Forecast by Type (2024-2029) & (US$/Unit)
Table 40. Global Medical Antifungal Agent Sales by Application (2018-2024) & (K Units)
Table 41. Global Medical Antifungal Agent Sales by Application (2024-2029) & (K Units)
Table 42. Global Medical Antifungal Agent Sales Share by Application (2018-2024)
Table 43. Global Medical Antifungal Agent Sales Share by Application (2024-2029)
Table 44. Global Medical Antifungal Agent Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Medical Antifungal Agent Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global Medical Antifungal Agent Revenue Share by Application (2018-2024)
Table 47. Global Medical Antifungal Agent Revenue Share by Application (2024-2029)
Table 48. Medical Antifungal Agent Price by Application (2018-2024) & (US$/Unit)
Table 49. Global Medical Antifungal Agent Price Forecast by Application (2024-2029) & (US$/Unit)
Table 50. US & Canada Medical Antifungal Agent Sales by Type (2018-2024) & (K Units)
Table 51. US & Canada Medical Antifungal Agent Sales by Type (2024-2029) & (K Units)
Table 52. US & Canada Medical Antifungal Agent Revenue by Type (2018-2024) & (US$ Million)
Table 53. US & Canada Medical Antifungal Agent Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada Medical Antifungal Agent Sales by Application (2018-2024) & (K Units)
Table 55. US & Canada Medical Antifungal Agent Sales by Application (2024-2029) & (K Units)
Table 56. US & Canada Medical Antifungal Agent Revenue by Application (2018-2024) & (US$ Million)
Table 57. US & Canada Medical Antifungal Agent Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada Medical Antifungal Agent Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada Medical Antifungal Agent Revenue by Country (2018-2024) & (US$ Million)
Table 60. US & Canada Medical Antifungal Agent Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada Medical Antifungal Agent Sales by Country (2018-2024) & (K Units)
Table 62. US & Canada Medical Antifungal Agent Sales by Country (2024-2029) & (K Units)
Table 63. Europe Medical Antifungal Agent Sales by Type (2018-2024) & (K Units)
Table 64. Europe Medical Antifungal Agent Sales by Type (2024-2029) & (K Units)
Table 65. Europe Medical Antifungal Agent Revenue by Type (2018-2024) & (US$ Million)
Table 66. Europe Medical Antifungal Agent Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe Medical Antifungal Agent Sales by Application (2018-2024) & (K Units)
Table 68. Europe Medical Antifungal Agent Sales by Application (2024-2029) & (K Units)
Table 69. Europe Medical Antifungal Agent Revenue by Application (2018-2024) & (US$ Million)
Table 70. Europe Medical Antifungal Agent Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe Medical Antifungal Agent Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe Medical Antifungal Agent Revenue by Country (2018-2024) & (US$ Million)
Table 73. Europe Medical Antifungal Agent Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe Medical Antifungal Agent Sales by Country (2018-2024) & (K Units)
Table 75. Europe Medical Antifungal Agent Sales by Country (2024-2029) & (K Units)
Table 76. China Medical Antifungal Agent Sales by Type (2018-2024) & (K Units)
Table 77. China Medical Antifungal Agent Sales by Type (2024-2029) & (K Units)
Table 78. China Medical Antifungal Agent Revenue by Type (2018-2024) & (US$ Million)
Table 79. China Medical Antifungal Agent Revenue by Type (2024-2029) & (US$ Million)
Table 80. China Medical Antifungal Agent Sales by Application (2018-2024) & (K Units)
Table 81. China Medical Antifungal Agent Sales by Application (2024-2029) & (K Units)
Table 82. China Medical Antifungal Agent Revenue by Application (2018-2024) & (US$ Million)
Table 83. China Medical Antifungal Agent Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia Medical Antifungal Agent Sales by Type (2018-2024) & (K Units)
Table 85. Asia Medical Antifungal Agent Sales by Type (2024-2029) & (K Units)
Table 86. Asia Medical Antifungal Agent Revenue by Type (2018-2024) & (US$ Million)
Table 87. Asia Medical Antifungal Agent Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia Medical Antifungal Agent Sales by Application (2018-2024) & (K Units)
Table 89. Asia Medical Antifungal Agent Sales by Application (2024-2029) & (K Units)
Table 90. Asia Medical Antifungal Agent Revenue by Application (2018-2024) & (US$ Million)
Table 91. Asia Medical Antifungal Agent Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia Medical Antifungal Agent Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia Medical Antifungal Agent Revenue by Region (2018-2024) & (US$ Million)
Table 94. Asia Medical Antifungal Agent Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia Medical Antifungal Agent Sales by Region (2018-2024) & (K Units)
Table 96. Asia Medical Antifungal Agent Sales by Region (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Medical Antifungal Agent Sales by Type (2018-2024) & (K Units)
Table 98. Middle East, Africa and Latin America Medical Antifungal Agent Sales by Type (2024-2029) & (K Units)
Table 99. Middle East, Africa and Latin America Medical Antifungal Agent Revenue by Type (2018-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Medical Antifungal Agent Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America Medical Antifungal Agent Sales by Application (2018-2024) & (K Units)
Table 102. Middle East, Africa and Latin America Medical Antifungal Agent Sales by Application (2024-2029) & (K Units)
Table 103. Middle East, Africa and Latin America Medical Antifungal Agent Revenue by Application (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Medical Antifungal Agent Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Medical Antifungal Agent Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America Medical Antifungal Agent Revenue by Country (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Medical Antifungal Agent Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Medical Antifungal Agent Sales by Country (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Medical Antifungal Agent Sales by Country (2024-2029) & (K Units)
Table 110. Novartis Company Information
Table 111. Novartis Description and Major Businesses
Table 112. Novartis Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Novartis Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Novartis Recent Developments
Table 115. Pfizer Company Information
Table 116. Pfizer Description and Major Businesses
Table 117. Pfizer Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Pfizer Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Pfizer Recent Developments
Table 120. Bayer Company Information
Table 121. Bayer Description and Major Businesses
Table 122. Bayer Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Bayer Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Bayer Recent Developments
Table 125. Sanofi Company Information
Table 126. Sanofi Description and Major Businesses
Table 127. Sanofi Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Sanofi Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Sanofi Recent Developments
Table 130. Merck & Co Company Information
Table 131. Merck & Co Description and Major Businesses
Table 132. Merck & Co Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Merck & Co Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Merck & Co Recent Developments
Table 135. GlaxoSmithKline Company Information
Table 136. GlaxoSmithKline Description and Major Businesses
Table 137. GlaxoSmithKline Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. GlaxoSmithKline Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. GlaxoSmithKline Recent Developments
Table 140. MSD Manuals Company Information
Table 141. MSD Manuals Description and Major Businesses
Table 142. MSD Manuals Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. MSD Manuals Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. MSD Manuals Recent Developments
Table 145. Abbott Company Information
Table 146. Abbott Description and Major Businesses
Table 147. Abbott Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Abbott Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Abbott Recent Developments
Table 150. Glenmark Company Information
Table 151. Glenmark Description and Major Businesses
Table 152. Glenmark Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Glenmark Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Glenmark Recent Developments
Table 155. Enzon Pharmaceuticals Company Information
Table 156. Enzon Pharmaceuticals Description and Major Businesses
Table 157. Enzon Pharmaceuticals Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Enzon Pharmaceuticals Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Enzon Pharmaceuticals Recent Developments
Table 160. Astellas Pharma Company Information
Table 161. Astellas Pharma Description and Major Businesses
Table 162. Astellas Pharma Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Astellas Pharma Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Astellas Pharma Recent Developments
Table 165. Scynexis Company Information
Table 166. Scynexis Description and Major Businesses
Table 167. Scynexis Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Scynexis Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Scynexis Recent Developments
Table 170. Cidara Therapeutics Company Information
Table 171. Cidara Therapeutics Description and Major Businesses
Table 172. Cidara Therapeutics Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. Cidara Therapeutics Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Cidara Therapeutics Recent Developments
Table 175. Lucigen Corporation Company Information
Table 176. Lucigen Corporation Description and Major Businesses
Table 177. Lucigen Corporation Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 178. Lucigen Corporation Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Lucigen Corporation Recent Developments
Table 180. Biosergen Company Information
Table 181. Biosergen Description and Major Businesses
Table 182. Biosergen Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 183. Biosergen Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Biosergen Recent Developments
Table 185. F2G Company Information
Table 186. F2G Description and Major Businesses
Table 187. F2G Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 188. F2G Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. F2G Recent Developments
Table 190. Sichuan Meidakang Pharmaceutical Company Information
Table 191. Sichuan Meidakang Pharmaceutical Description and Major Businesses
Table 192. Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 193. Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. Sichuan Meidakang Pharmaceutical Recent Developments
Table 195. Chengdu Taihe Health Technology Company Information
Table 196. Chengdu Taihe Health Technology Description and Major Businesses
Table 197. Chengdu Taihe Health Technology Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 198. Chengdu Taihe Health Technology Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 199. Chengdu Taihe Health Technology Recent Developments
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Medical Antifungal Agent Distributors List
Table 203. Medical Antifungal Agent Customers List
Table 204. Medical Antifungal Agent Market Trends
Table 205. Medical Antifungal Agent Market Drivers
Table 206. Medical Antifungal Agent Market Challenges
Table 207. Medical Antifungal Agent Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Medical Antifungal Agent Product Picture
Figure 2. Global Medical Antifungal Agent Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Medical Antifungal Agent Market Share by Type in 2022 & 2029
Figure 4. Azoles Product Picture
Figure 5. Echinocandins Product Picture
Figure 6. Polyenes Product Picture
Figure 7. Allylamines Product Picture
Figure 8. Others Product Picture
Figure 9. Global Medical Antifungal Agent Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Medical Antifungal Agent Market Share by Application in 2022 & 2029
Figure 11. Dermatophytosis
Figure 12. Aspergillosis
Figure 13. Candidiasis
Figure 14. Others
Figure 15. Medical Antifungal Agent Report Years Considered
Figure 16. Global Medical Antifungal Agent Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Medical Antifungal Agent Revenue 2018-2029 (US$ Million)
Figure 18. Global Medical Antifungal Agent Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 19. Global Medical Antifungal Agent Revenue Market Share by Region (2018-2029)
Figure 20. Global Medical Antifungal Agent Sales 2018-2029 ((K Units)
Figure 21. Global Medical Antifungal Agent Sales Market Share by Region (2018-2029)
Figure 22. US & Canada Medical Antifungal Agent Sales YoY (2018-2029) & (K Units)
Figure 23. US & Canada Medical Antifungal Agent Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Europe Medical Antifungal Agent Sales YoY (2018-2029) & (K Units)
Figure 25. Europe Medical Antifungal Agent Revenue YoY (2018-2029) & (US$ Million)
Figure 26. China Medical Antifungal Agent Sales YoY (2018-2029) & (K Units)
Figure 27. China Medical Antifungal Agent Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Asia (excluding China) Medical Antifungal Agent Sales YoY (2018-2029) & (K Units)
Figure 29. Asia (excluding China) Medical Antifungal Agent Revenue YoY (2018-2029) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Medical Antifungal Agent Sales YoY (2018-2029) & (K Units)
Figure 31. Middle East, Africa and Latin America Medical Antifungal Agent Revenue YoY (2018-2029) & (US$ Million)
Figure 32. The Medical Antifungal Agent Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 33. The Top 5 and 10 Largest Manufacturers of Medical Antifungal Agent in the World: Market Share by Medical Antifungal Agent Revenue in 2022
Figure 34. Global Medical Antifungal Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 35. Global Medical Antifungal Agent Sales Market Share by Type (2018-2029)
Figure 36. Global Medical Antifungal Agent Revenue Market Share by Type (2018-2029)
Figure 37. Global Medical Antifungal Agent Sales Market Share by Application (2018-2029)
Figure 38. Global Medical Antifungal Agent Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Medical Antifungal Agent Sales Market Share by Type (2018-2029)
Figure 40. US & Canada Medical Antifungal Agent Revenue Market Share by Type (2018-2029)
Figure 41. US & Canada Medical Antifungal Agent Sales Market Share by Application (2018-2029)
Figure 42. US & Canada Medical Antifungal Agent Revenue Market Share by Application (2018-2029)
Figure 43. US & Canada Medical Antifungal Agent Revenue Share by Country (2018-2029)
Figure 44. US & Canada Medical Antifungal Agent Sales Share by Country (2018-2029)
Figure 45. U.S. Medical Antifungal Agent Revenue (2018-2029) & (US$ Million)
Figure 46. Canada Medical Antifungal Agent Revenue (2018-2029) & (US$ Million)
Figure 47. Europe Medical Antifungal Agent Sales Market Share by Type (2018-2029)
Figure 48. Europe Medical Antifungal Agent Revenue Market Share by Type (2018-2029)
Figure 49. Europe Medical Antifungal Agent Sales Market Share by Application (2018-2029)
Figure 50. Europe Medical Antifungal Agent Revenue Market Share by Application (2018-2029)
Figure 51. Europe Medical Antifungal Agent Revenue Share by Country (2018-2029)
Figure 52. Europe Medical Antifungal Agent Sales Share by Country (2018-2029)
Figure 53. Germany Medical Antifungal Agent Revenue (2018-2029) & (US$ Million)
Figure 54. France Medical Antifungal Agent Revenue (2018-2029) & (US$ Million)
Figure 55. U.K. Medical Antifungal Agent Revenue (2018-2029) & (US$ Million)
Figure 56. Italy Medical Antifungal Agent Revenue (2018-2029) & (US$ Million)
Figure 57. Russia Medical Antifungal Agent Revenue (2018-2029) & (US$ Million)
Figure 58. China Medical Antifungal Agent Sales Market Share by Type (2018-2029)
Figure 59. China Medical Antifungal Agent Revenue Market Share by Type (2018-2029)
Figure 60. China Medical Antifungal Agent Sales Market Share by Application (2018-2029)
Figure 61. China Medical Antifungal Agent Revenue Market Share by Application (2018-2029)
Figure 62. Asia Medical Antifungal Agent Sales Market Share by Type (2018-2029)
Figure 63. Asia Medical Antifungal Agent Revenue Market Share by Type (2018-2029)
Figure 64. Asia Medical Antifungal Agent Sales Market Share by Application (2018-2029)
Figure 65. Asia Medical Antifungal Agent Revenue Market Share by Application (2018-2029)
Figure 66. Asia Medical Antifungal Agent Revenue Share by Region (2018-2029)
Figure 67. Asia Medical Antifungal Agent Sales Share by Region (2018-2029)
Figure 68. Japan Medical Antifungal Agent Revenue (2018-2029) & (US$ Million)
Figure 69. South Korea Medical Antifungal Agent Revenue (2018-2029) & (US$ Million)
Figure 70. China Taiwan Medical Antifungal Agent Revenue (2018-2029) & (US$ Million)
Figure 71. Southeast Asia Medical Antifungal Agent Revenue (2018-2029) & (US$ Million)
Figure 72. India Medical Antifungal Agent Revenue (2018-2029) & (US$ Million)
Figure 73. Middle East, Africa and Latin America Medical Antifungal Agent Sales Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Medical Antifungal Agent Revenue Market Share by Type (2018-2029)
Figure 75. Middle East, Africa and Latin America Medical Antifungal Agent Sales Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Medical Antifungal Agent Revenue Market Share by Application (2018-2029)
Figure 77. Middle East, Africa and Latin America Medical Antifungal Agent Revenue Share by Country (2018-2029)
Figure 78. Middle East, Africa and Latin America Medical Antifungal Agent Sales Share by Country (2018-2029)
Figure 79. Brazil Medical Antifungal Agent Revenue (2018-2029) & (US$ Million)
Figure 80. Mexico Medical Antifungal Agent Revenue (2018-2029) & (US$ Million)
Figure 81. Turkey Medical Antifungal Agent Revenue (2018-2029) & (US$ Million)
Figure 82. Israel Medical Antifungal Agent Revenue (2018-2029) & (US$ Million)
Figure 83. GCC Countries Medical Antifungal Agent Revenue (2018-2029) & (US$ Million)
Figure 84. Medical Antifungal Agent Value Chain
Figure 85. Medical Antifungal Agent Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed